Log In
BCIQ
Print this Print this
 

Thymidylate synthetase (TYMS)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Thymidylate synthetase (TYMS)

BCIQ
Print ChartPrint this
1 - Dermatology 3 - Cancer 1 - Cancer 1 - Cancer 1 - Cancer
Phase of DevelopmentPhase IPhase IIIApprovedMarketed
Cancer

1

1

1

3

Dermatology

-

-

-

1




 Products Targeting Thymidylate synthetase (TYMS)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$452.5M

$422.5M

$30.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

07/18/2011

$422.5M

$422.5M

0

06/14/2010

$30.0M

0

$30.0M

Get a free BioCentury Trial today